Combined with previous studies, we assumed that the local anesthetic ropivacaine potentially participated in hepatocellular carcinoma progression by regulating the IGF-1 R-PI3K-Akt-mTOR signaling pathway. This evidence concerns the gene AKT1 and hepatocellular carcinoma.